Imaging Technology

OCTOBER 21, 2024

21, 2024 — Siemens Healthineers recently received Food and Drug Administration clearance for two new features in its syngo.PET Cortical Analysis software application that use positron emission tomography (PET) to measure protein deposits in the brain associated with Alzheimer’s disease. tim.hodson Mon, 10/21/2024 - 10:17 Oct.

Disease 52

Disease Radiopharmaceuticals PET Scan Clinic 52

Imaging Technology

JANUARY 5, 2024

This leading radiopharmaceutical platform provides detailed PET imaging-based diagnosis and dosimetry using long-lived copper-64 ( 64 Cu) for imaging and alpha-particle targeted RPT using lead-212 ( 212 Pb). milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc.

Radiopharmaceuticals 104

Radiopharmaceuticals Clinic Nuclear Medicine Radiation 104

AuntMinnie

SEPTEMBER 13, 2023

Read more on AuntMinnie.com Related Reading: ACR urges full coverage for amyloid PET scans CMS proposal covers PET scans for Alzheimer’s disease MITA praises FDA for Leqembi approval FIND Act reintroduced in U.S. Senate MITA hails radiopharmaceutical legislation

Radiopharmaceuticals 52

Radiopharmaceuticals PET Scan Medical Imaging Disease 52

Imaging Technology

JULY 25, 2023

By leveraging our expertise in radiopharmaceuticals, we aim to contribute to the early detection and accurate monitoring of epithelial-derived cancers. This further strengthens our commitment to production and development of novel radiopharmaceuticals to advance cancer treatments and quality of life for cancer patients."

Radiopharmaceuticals 98

Radiopharmaceuticals Imaging Pharmaceutical Disease 98

Imaging Technology

JULY 11, 2023

By leveraging our expertise in radiopharmaceuticals, we aim to contribute to the early detection and accurate monitoring of epithelial-derived cancers. This partnership exemplifies our commitment to Find, Fight and Follow disease by delivering innovative solutions to improve cancer care, ultimately leading to better patient outcomes."

Radiopharmaceuticals 75

Radiopharmaceuticals Imaging Pharmaceutical Disease 75

Imaging Technology

APRIL 5, 2024

milla1cf Fri, 04/05/2024 - 11:31 April 5, 2024 — RLS Radiopharmacies , America’s only Joint Commission-accredited radiopharmacy network, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement with global isotope technology leader Eckert & Ziegler.

Radiopharmaceuticals 52

Radiopharmaceuticals Radiation Oncology Radiation Quality and Compliance 52

Imaging Technology

NOVEMBER 7, 2024

Under the new policy, CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630, removing financial barriers that have long hindered patient access to essential nuclear medicine diagnostic procedures. tim.hodson Thu, 11/07/2024 - 11:25 Nov.

Nuclear Medicine 97

Nuclear Medicine Radiopharmaceuticals Medicare Diagnostic 97

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

AuntMinnie

JANUARY 19, 2024

more than 6 million Americans have Alzheimer's disease, a debilitating and far-reaching disease that accounts for 60% to 80% of dementia cases, and by 2050, this number is projected to rise to nearly 13 million, according to Alzheimer’s Disease International. The disease affects memory, thinking, and behavior. In the U.S.,

Disease 52

Disease Medicare Imaging PET Scan 52

Open Medscience

OCTOBER 6, 2024

Chronic disease management focuses on improving patient outcomes through personalised care, preventative measures, and technological advancements. The post Innovations in Chronic Disease Management: A New Frontier for Diabetes, Cardiovascular Disease, and Hypertension appeared first on Open MedScience.

Disease 52

Disease Radiopharmaceuticals Diagnostic 52

AuntMinnie

JULY 10, 2024

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Imaging Medicare 122

Open Medscience

AUGUST 9, 2024

Radiopharmacy combines the disciplines of pharmacy and nuclear science to create radiopharmaceuticals, revolutionising the diagnosis and treatment of diseases. The post Radiopharmacy: Harnessing Radioactive Compounds for Diagnosis and Treatment appeared first on Open MedScience.

Radiopharmaceuticals 52

Radiopharmaceuticals Disease 52

AuntMinnie

SEPTEMBER 30, 2024

A radiopharmaceutical therapy that lengthens progression-free survival for patients with neuroendocrine cancer could help treat meningioma sufferers, according to research presented at the American Society for Radiation Oncology (ASTRO) meeting. Nearly 80% of patients in our study were progression-free after six months," he said.

Radiation Oncology 119

Radiation Oncology Radiopharmaceuticals Radiation Clinic 119

Open Medscience

NOVEMBER 9, 2023

Alzheimer's disease stems from genetic mutations and lifestyle factors, leading to brain plaque accumulation and dementia. The post Unveiling the Complex Etiology and Innovative Diagnostic Approaches in Alzheimer’s Disease appeared first on Open Medscience.

Disease 59

Disease Diagnostic Nuclear Medicine Radiopharmaceuticals 59

AuntMinnie

SEPTEMBER 25, 2024

Centers for Medicare and Medicaid Services (CMS) to “unbundle” payments for diagnostic radiopharmaceuticals from the cost of nuclear medicine tests, cardiac SPECT procedures may get the short end of the stick, said Lawrence Phillips, MD, of NYU Langone Health in New York City, in an interview with AuntMinnie.com.

Radiopharmaceuticals 64

Radiopharmaceuticals Nuclear Medicine Medicare Diagnostic 64

AuntMinnie

APRIL 4, 2024

Life Molecular Imaging (LMI) and Sofie Biosciences have begun offering the Neuraceq ( florbetaben F-18) PET radiotracer produced at Sofie's radiopharmaceutical manufacturing site in Cleveland, Ohio. With this expansion, LMI continues driving commercial sales of Neuraceq around the U.S.

Radiopharmaceuticals 95

Radiopharmaceuticals Imaging Disease Diagnostic 95

Imaging Technology

JUNE 10, 2024

More recently, she and her collaborators developed a PET imaging agent for vaso-occlusive crisis in sickle cell disease, recently approved for human studies by the FDA as an Investigational New Drug. Louis , Missouri, where she worked more than 20 years developing PET and radiopharmaceutical therapy agents.

Nuclear Medicine 104

Nuclear Medicine Radiopharmaceuticals Disease Imaging 104

Open Medscience

AUGUST 11, 2024

Pittsburgh Compound-B allows researchers to visualise amyloid plaques in the brain, aiding in Alzheimer's disease diagnosis and study. The post The Discovery and Development of Pittsburgh Compound-B (PIB): A Breakthrough in Alzheimer’s Disease Research appeared first on Open MedScience.

Disease 40

Disease Nuclear Medicine Radiopharmaceuticals Imaging 40

AuntMinnie

AUGUST 22, 2024

Food and Drug Administration (FDA) has granted Clarity Pharmaceuticals fast-track designation for its copper-64 (Cu-64) sarcophagine (SAR) bisPSMA radiopharmaceutical.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Disease Clinic 52

Imaging Technology

MAY 14, 2024

Siemens Healthineers and UH will look to also advance the treatment of patients with Alzheimer’s disease and use theranostics—combining the approaches of diagnostics and therapeutics—to treat patients with advanced forms of certain cancers, as well as develop new magnetic resonance ( MR ) technologies. tesla and 3T scanners.

Hospital 116

Hospital Magnetic Resonance Imaging Radiopharmaceuticals Disease 116

Imaging Technology

APRIL 28, 2023

Molecular imaging enables doctors and clinicians to see inside the body with a non-invasive process, helping to diagnose and treat diseases such as cancer, cardiovascular disease , and neurological diseases. It uses biomarkers to highlight molecular changes, which can sometimes alert doctors to possible disease.

Healthcare 98

Healthcare Healthcare Radiopharmaceuticals PET Scan 98

AuntMinnie

AUGUST 2, 2024

CereMark Pharma, a radiopharmaceutical company focused on neurodegenerative diseases, is planning a phase III clinical trial later this year to investigate the novel PET imaging agent F-18 flornaptitril.

Radiopharmaceuticals 52

Radiopharmaceuticals Disease Clinic IT 52

AuntMinnie

JULY 10, 2024

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Medicare 52

Medicare Nuclear Medicine Radiopharmaceuticals Imaging 52

Imaging Technology

AUGUST 29, 2023

Alan Taylor , stated, “Large-scale manufacture of therapeutic Cu-67 from highly efficient, environmentally preferable electron accelerators is critical to overcome the widespread supply issues in the radiopharmaceutical industry, due to a heavy reliance on a small number of antiquated nuclear reactors.

Pharmaceutical 97

Pharmaceutical Radiopharmaceuticals Clinic Medical 97

AuntMinnie

AUGUST 12, 2024

SPECT/CT imaging can help manage patients undergoing radiopharmaceutical therapy (RPT) with Pluvicto for advanced prostate cancer, according to a study published August 8 in the Journal of Nuclear Medicine. Yet whether SPECT/CT can be used to determine disease progression or response has yet to be delineated, they noted.

Nuclear Medicine 104

Nuclear Medicine Bone Scan Disease Radiopharmaceuticals 104

Imaging Technology

AUGUST 31, 2023

milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 for use in radiopharmaceutical therapy (RPT). actinium-225 (Ac-225). “As a company at the forefront of U.S.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

AuntMinnie

AUGUST 20, 2024

Life Molecular Imaging and PharmaLogic Holdings have inked a partnership and licensing agreement to provide and distribute the imaging agent Neuraceq from PharmaLogic's radiopharmaceutical manufacturing site near Denver, CO. Neuraceq is a diagnostic agent cleared by the U.S. Food and Drug Administration (FDA) for PET imaging of the brain.

Radiopharmaceuticals 40

Radiopharmaceuticals Disease Diagnostic Clinic 40

Imaging Technology

DECEMBER 6, 2023

and Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today provided additional information regarding a March 2022 licensing and collaboration agreement between Philochem and Blue Earth Diagnostics. Chief Executive Officer of Blue Earth Diagnostics.

Diagnostic 105

Diagnostic Diagnostic Imaging Clinic Radiopharmaceuticals 105

Imaging Technology

JULY 5, 2023

Ac-225 is a high energy alpha-emitting radioisotope of increasing interest for clinical studies investigating the use of targeted radiopharmaceutical therapy, which combines select molecules with therapeutic radioisotopes to directly target and deliver therapeutic doses of radiation to destroy cancer cells in patients with serious disease.

Medical 92

Medical Radiopharmaceuticals Pharmaceutical Radiation 92

AuntMinnie

DECEMBER 8, 2023

Suspicion of malignancy may be prompted by avid uptake of the radiopharmaceutical FDG on PET/CT imaging, according to study results delivered on November 27 at the RSNA meeting. Accurate diagnosis of organizing pneumonia is confounded by the co-existence of [the condition] with lung malignancies," Kim said.

Imaging 123

Imaging Radiopharmaceuticals Disease Diagnose 123

AuntMinnie

JUNE 9, 2024

Her research also contributed to FDA approval of Lu-177 DOTATATE for treating neuroendocrine tumors; recently, she and collaborators developed a PET imaging agent for vaso-occlusive crisis in sickle cell disease, which has been approved for human studies by the FDA as an Investigational New Drug (IND).

Nuclear Medicine 98

Nuclear Medicine Radiopharmaceuticals Disease Imaging 98

Imaging Technology

AUGUST 23, 2023

SCINTIX therapy is a cutting-edge radiopharmaceutical-directed treatment applicable for early and late-stage cancers that uses the individual biology of each tumor to drive its own treatment. “We founder and CTO of RefleXion.

Radiopharmaceuticals 98

Radiopharmaceuticals Disease Radiation Clinic 98

Imaging Technology

OCTOBER 4, 2024

As Theranostics and the use of radiopharmaceutical therapy (RPT) to treat cancer and other diseases have become more prevalent, interest in using dosimetry to personalize RPT treatments has grown. Dosimetry in Radiopharmaceutical Therapy. J Nucl Med. 2022 Oct;63(10):1467-1474. doi: 10.2967/jnumed.121.262305. 121.262305. [ii]

Radiopharmaceuticals 52

Radiopharmaceuticals Nuclear Medicine Radiation Healthcare 52

AuntMinnie

FEBRUARY 12, 2024

Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PET imaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. of patients, noted lead author Ke-Liang Chen, MD, a neurologist at Fudan University.

PET Scan 104

PET Scan Diagnose Disease Radiopharmaceuticals 104

Imaging Technology

JUNE 19, 2023

milla1cf Mon, 06/19/2023 - 19:27 June 19, 2023 — NorthStar Medical Technologies, LLC , a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Frank Scholz, Ph.D., NorthStar’s commercialized, U.S.-based

Medical 98

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 98

Imaging Technology

AUGUST 28, 2023

This volume would be equivalent to 50% of today’s supply and would underpin the wider development of these targeted alpha therapy radiopharmaceuticals as an effective treatment modality for cancer", commented Sven Van den Berghe, PanTera’s Chief Executive Officer.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Medical Clinic 98